Historical Valuation
Insmed Inc (INSM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 40.31 is considered Overvalued compared with the five-year average of -10.98. The fair price of Insmed Inc (INSM) is between 35.10 to 111.22 according to relative valuation methord. Compared to the current price of 170.27 USD , Insmed Inc is Overvalued By 53.09%.
Relative Value
Fair Zone
35.10-111.22
Current Price：170.27
53.09%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Insmed Inc (INSM) has a current Price-to-Book (P/B) ratio of 39.82. Compared to its 3-year average P/B ratio of 47.29 , the current P/B ratio is approximately -15.79% higher. Relative to its 5-year average P/B ratio of 31.03, the current P/B ratio is about 28.34% higher. Insmed Inc (INSM) has a Forward Free Cash Flow (FCF) yield of approximately -2.40%. Compared to its 3-year average FCF yield of -9.45%, the current FCF yield is approximately -74.62% lower. Relative to its 5-year average FCF yield of -10.36% , the current FCF yield is about -76.84% lower.
P/B
Median3y
47.29
Median5y
31.03
FCF Yield
Median3y
-9.45
Median5y
-10.36
Competitors Valuation Multiple
AI Analysis for INSM
The average P/S ratio for INSM competitors is 10.90, providing a benchmark for relative valuation. Insmed Inc Corp (INSM.O) exhibits a P/S ratio of 40.31, which is 269.73% above the industry average. Given its robust revenue growth of 52.36%, this premium appears sustainable.
Performance Decomposition
AI Analysis for INSM
1Y
3Y
5Y
Market capitalization of INSM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of INSM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is INSM currently overvalued or undervalued?
Insmed Inc (INSM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 40.31 is considered Overvalued compared with the five-year average of -10.98. The fair price of Insmed Inc (INSM) is between 35.10 to 111.22 according to relative valuation methord. Compared to the current price of 170.27 USD , Insmed Inc is Overvalued By 53.09% .
What is Insmed Inc (INSM) fair value?
INSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Insmed Inc (INSM) is between 35.10 to 111.22 according to relative valuation methord.
How does INSM's valuation metrics compare to the industry average?
The average P/S ratio for INSM's competitors is 10.90, providing a benchmark for relative valuation. Insmed Inc Corp (INSM) exhibits a P/S ratio of 40.31, which is 269.73% above the industry average. Given its robust revenue growth of 52.36%, this premium appears sustainable.
What is the current P/B ratio for Insmed Inc (INSM) as of Jan 09 2026?
As of Jan 09 2026, Insmed Inc (INSM) has a P/B ratio of 39.82. This indicates that the market values INSM at 39.82 times its book value.
What is the current FCF Yield for Insmed Inc (INSM) as of Jan 09 2026?
As of Jan 09 2026, Insmed Inc (INSM) has a FCF Yield of -2.40%. This means that for every dollar of Insmed Inc’s market capitalization, the company generates -2.40 cents in free cash flow.
What is the current Forward P/E ratio for Insmed Inc (INSM) as of Jan 09 2026?
As of Jan 09 2026, Insmed Inc (INSM) has a Forward P/E ratio of -40.55. This means the market is willing to pay $-40.55 for every dollar of Insmed Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Insmed Inc (INSM) as of Jan 09 2026?
As of Jan 09 2026, Insmed Inc (INSM) has a Forward P/S ratio of 40.31. This means the market is valuing INSM at $40.31 for every dollar of expected revenue over the next 12 months.